In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 343-345

  Larsen, R A ^a   Bauer, M ^a   Brouwer, A E ^b,c,d   Sanchez, A ^a   Thomas, A M ^e   Rajanuwong, A ^f   Chierakul, W ^b   Peacock, S J ^b,g   Day, N ^b,g   White, N J ^b,g   Rinaldi, M G ^h   Harrison, T S ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF NORTHERN COLORADO   (United States)

^f Sappasitthiprasong Hospital   (Thailand)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; FUNGAL MENINGITIS; HUMAN; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; HUMANS; MENINGITIS, CRYPTOCOCCAL; MICROBIAL SENSITIVITY TESTS; REGRESSION ANALYSIS;

EID: 33845983323     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00742-06     Document Type: Article

References (13)

1. Brouwer, A. E., A. Rajanuwong, W. Chierakul, G. E. Griffin, R. A. Larsen, N. J. White, and T. S. Harrison. 2004. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 363: 1764-1767.
2. Brouwer, A. E., P. Teparrukkul, S. Pinpraphaporn, R. A. Larsen, W. Chierakul, S. Peacock, N. Day, N. J. White, and T. S. Harrison. 2005. Baseline correlation and comparative kinetics of cerebrospinal colony-forming unit counts and antigen titers in cryptococcal meningitis. J. Infect. Dis. 192:681-684.
3. Cleveland, W. S. 1993. Visualizing data. Hobart, Summit, NJ.
4. Cleveland, W. S., E. Grosse, and W. M. Shyu. 1991. Local regression models, p. 309-376. In J. M. Chambers and T. Hastie (ed.), Statistical models in S. Chapman and Hall, New York, NY.
5. Dannaoui, E., M. Abdul, M. Arpin, A. Michel-Nguyen, M. A. Piens, A. Favel, O. Lortholary, F. Dromer, and the French Cryptococcosis Study Group. 2006. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob. Agents Chemother. 50:2464-2470.
6. Hollander, M., and D. A. Wolfe. 1973. Nonparametric statistical methods. Wiley, New York, NY.
7. Larsen, R. A., M. Bauer, A. M. Thomas, and J. R. Graybill. 2004. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob. Agents Chemother. 48:985-991.
8. Larsen, R. A., M. Bauer, A. M. Thomas, A. Sanchez, D. Citron, M. Rathbun, and T. S. Harrison. 2005. Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans. Antimicrob. Agents Chemother. 49:3297-3301.
9. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd ed. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
10. Pfaller, M. A., and W. L. Yu. 2001. Antifungal susceptibility testing. New technology and clinical applications. Infect. Dis. Clin. N. Am. 15:1227-1261.
11. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, A. L. Barry, and the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
12. Robinson, P. A., M. Bauer, M. A. Leal, S. G. Evans, P. D. Holtom, D. A. Diamond, J. M. Leedom, and R. A. Larsen. 1999. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin. Infect. Dis. 28:82-92.
13. van der Horst, C. M., M. S. Saag, G. A. Cloud, R. J. Hamill, J. R. Graybill, J. D. Sobel, P. C. Johnson, C. U. Tuazon, T. Kerkering, B. L. Moskovitz, W. G. Powderly, and W. E. Dismukes. 1997. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N. Engl. J. Med. 337:15-21.